Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA's Center for Drug Evaluation and Research Janet Woodcock, M.D., on the FDA's continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abro

[In The News]

SILVER SPRING, Md., Feb. 22, 2019 /PRNewswire/ -- At the FDA, protecting patient and consumer health is our highest priority. Assessing and mitigating risks is at the heart of everything we do across our vast portfolio. Sometimes the actions we take are visible, like warning letters or...

View the full article